Astera Labs, Inc. reported $1.20B of revenue over the trailing twelve months, +98% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $1.20B (to Q2 2026). Net income: $369M, trailing twelve months to Q2 2026. Free cash flow: $277M, trailing twelve months to Q2 2026. Operating margin: 23%, trailing twelve months to Q2 2026.

ALABAstera Labs, Inc.

Technology

$342.14+40% 1Y

$342.14

$100.2752 weeks$439.66

ALAB as reported

Astera Labs, Inc. reported $1.20B of revenue over the trailing twelve months, +98% on the year before. 10 reported series are charted on this page, each one as filed.

$1.20B

Revenue, trailing twelve months · to Q2 2026 · +98% against the twelve months before

Net income: $369M
Net income · +269% year on year · trailing twelve months to Q2 2026
Free cash flow: $277M
Free cash flow · +32% year on year · trailing twelve months to Q2 2026
Operating margin: 23%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for ALAB, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$1.20B	+98%	Q2 2026
Net income	$369M	+269%	Q2 2026
EPS	$2.02	+201%	Q2 2026
Gross margin	75%	n/a	Q2 2026
Operating margin	23%	n/a	Q2 2026
Net margin	30%	n/a	Q2 2026
ROE	18%	n/a	Q2 2026
ROA	16%	n/a	Q2 2026
Free cash flow	$277M	+32%	Q2 2026
P/E	169	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.